Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Shares Outstanding (2016 - 2025)

Wave Life Sciences' Shares Outstanding history spans 11 years, with the latest figure at $187.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 22.62% year-over-year to $187.7 million; the TTM value through Dec 2025 reached $187.7 million, up 22.62%, while the annual FY2025 figure was $187.7 million, 22.62% up from the prior year.
  • Shares Outstanding reached $187.7 million in Q4 2025 per WVE's latest filing, up from $160.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $187.7 million in Q4 2025 to a low of $49.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $107.6 million, with a median of $98.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: tumbled 92.5% in 2022, then skyrocketed 2437.89% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $59.8 million in 2021, then soared by 45.26% to $86.9 million in 2022, then skyrocketed by 37.09% to $119.2 million in 2023, then increased by 28.43% to $153.0 million in 2024, then increased by 22.62% to $187.7 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Shares Outstanding are $187.7 million (Q4 2025), $160.3 million (Q3 2025), and $155.7 million (Q2 2025).